Moreover, expression of IGF-1 is lower in humans with obesity specifically within skeletal muscle (Sullivan et al., 2020), and which could more directly, when compared to plasma IGF-1, contribute to attenuating muscle protein synthesis in humans with obesity. This evidence concerns the gene IGF1 and obesity disorder.